Orgenesis Inc. Operating CF per Share

Operating CF per Share of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF per Share growth rates and interactive chart. Total operating cash flow in a period divided by the weighted average number of shares outstanding. A company with $100 million in operating cash flow and 10 million weighted average shares will have operating cash flow per share of $10.


Highlights and Quick Summary

  • Operating CF per Share for the quarter ending September 29, 2021 was -0.42 (a -5.05% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF per Share decreased by -77.5%
  • Annual Operating CF per Share for 2020 was -3.66 (a 340.51% increase from previous year)
  • Annual Operating CF per Share for 2019 was -0.83 (a -29.13% decrease from previous year)
  • Annual Operating CF per Share for 2018 was -1.17 (a -0.0% decrease from previous year)
  • Twelve month Operating CF per Share ending September 29, 2021 was -2.95 (a 0.7% increase compared to previous quarter)
  • Twelve month trailing Operating CF per Share decreased by -8.8% year-over-year
Trailing Operating CF per Share for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
-2.95 -2.92 -2.88 -3.23
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF per Share of Orgenesis Inc.

Most recent Operating CF per Shareof ORGS including historical data for past 10 years.

Interactive Chart of Operating CF per Share of Orgenesis Inc.

Orgenesis Inc. Operating CF per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -0.42 -0.44 -0.22
2020 -1.87 -0.45 -0.42 -0.77 -3.66
2019 -0.17 -0.15 -0.23 -0.29 -0.83
2018 -0.32 -0.39 -0.37 -0.19 -1.17
2017 -0.16 -0.23 0.0 0.04 -0.4
2016 0.0 -0.11 0.0 -0.24 -0.44
2015 0.0 -0.58
2014 0.0 -0.32
2013 0.0 -0.47
2012 0.0 0.0

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.